2U3:ETR
Alcon AG
€57.08
arrow_downward
-0.52%(-0.30) 1D
Oct 13, 3:14:35 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 2U3...
Open
€58.18
High
€58.18
Low
€57.08
Mkt. cap
26.53B
Avg. vol.
3.20K
Volume
7.65K
52-wk high
€74.62
52-wk low
€52.42
No. of employees
25K
Open
€58.18
High
€58.18
Low
€57.08
Mkt. cap
26.53B
Avg. vol.
3.20K
Volume
7.65K
52-wk high
€74.62
52-wk low
€52.42
No. of employees
25K
News stories
From web sources and news partners
ad-hoc-news.de
·
1 hour ago
Alcon schedules November 10 results as Alcon stock costs EUR 57.28
ad-hoc-news.de
·
20 hours ago
Alcon launches Systane PRO in Canada: stock after-hours at EUR 57.42
ad-hoc-news.de
·
1 day ago
Alcon posts 256-patient data while Alcon stock sits 21.38 percent below its high
ad-hoc-news.de
·
1 day ago
Alcon highlights AAO innovation as Alcon stock sits at EUR 57.28
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees25K
Founded1945
HeadquartersGeneva, Geneva, Switzerland
SectorMedical device
Websitealcon.com